Plasma arylsulfatase A levels are associated with cognitive function in Parkinson’s disease

被引:0
|
作者
Mingjian Li
Xiaoxue Shi
Jianjun Ma
Wenhua Sun
Zhidong Wang
Dongsheng Li
Jinhua Zheng
Zhenxiang Zhao
Qi Gu
Siyuan Chen
机构
[1] Henan University People’s Hospital,Department of Neurology
[2] Henan Provincial People’s Hospital,Department of Neurology
[3] Zhengzhou University People’s Hospital,Department of Neurology
来源
Neurological Sciences | 2022年 / 43卷
关键词
Parkinson’s disease; Arylsulfatase A; α-Synuclein; Cognitive function;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:4753 / 4759
页数:6
相关论文
共 50 条
  • [31] Higher serum triglyceride levels are associated with Parkinson's disease mild cognitive impairment
    Huang, Xinxin
    Ng, Samuel Yong-Ern
    Chia, Nicole Shuang-Yu
    Acharyya, Sanchalika
    Setiawan, Fiona
    Lu, Zhonghao
    Tan, Yi Jayne
    Ng, Ebonne
    Wen, Ming-Ching
    Ng, Adeline S. L.
    Tay, Kay-Yaw
    Au, Wing-Lok
    Tan, Eng-King
    Tan, Louis Chew-Seng
    [J]. MOVEMENT DISORDERS, 2018, 33 (12) : 1970 - 1971
  • [32] Altered BDNF levels are associated with cognitive impairment in Parkinson?s disease patients with depression
    Wang, Yu
    Bai, Li -Peng
    Liu, Wei
    Zhu, Xiao-Dong
    Zhang, Xiang -Yang
    [J]. PARKINSONISM & RELATED DISORDERS, 2022, 103 : 122 - 128
  • [33] Plasma homocysteine and cognitive impairment in Parkinson's disease
    Quinn, J. F.
    Jewell, S.
    Murchison, C.
    Carney, N.
    Lobb, B.
    O'Connor, S.
    Chung, K.
    Zabetian, C.
    Leverenz, J.
    Montine, T.
    Cholerton, B.
    Edwards, K.
    Peterson, A.
    [J]. MOVEMENT DISORDERS, 2014, 29 : S360 - S360
  • [34] Fasting Plasma Glucose Levels and Longitudinal Motor and Cognitive Outcomes in Parkinson's Disease Patients
    Choi, Ko-Eun
    Ryu, Dong-Woo
    Oh, Yoon-Sang
    Kim, Joong-Seok
    [J]. JOURNAL OF MOVEMENT DISORDERS, 2024, 17 (02) : 198 - 207
  • [35] Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson's disease
    Aarsland, Dag
    Rajkumar, Anto P.
    Hye, Abdul
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (10): : 808 - 808
  • [36] Influencing factors on cognitive function in Parkinson's disease
    Muminov, Bekzod
    Matmurodov, Rustambek
    Abdukodirov, Eldor
    Khalimova, Khanifa
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429 : 311 - 312
  • [37] Cognitive function assessment in idiopathic Parkinson's disease
    Piovezan, Mauro R.
    Teive, Helio A. G.
    Piovesan, Elcio J.
    Mader, Maria J.
    Wemeck, Lineu Cesar
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2007, 65 (4A) : 942 - 946
  • [38] Dopaminergic agonist and cognitive function in Parkinson's disease
    Relja, M
    Klepac, N
    Subotic, Z
    [J]. PERIODICUM BIOLOGORUM, 2002, 104 (01) : 43 - 45
  • [39] Cognitive function in Parkinson's disease: The influence of gender
    Chiara, Pasotti
    Roberta, Zangaglia
    Elena, Sinforiani
    Brigida, Minafra
    Ilaria, Bertaina
    Claudio, Pacchetti
    [J]. BASAL GANGLIA, 2013, 3 (02) : 131 - 135
  • [40] Cognitive function in Parkinson's disease: A selective review
    Paulus, KS
    Magnano, I
    Galistu, P
    Agnetti, V
    Deriu, MG
    Occhineri, C
    Aiello, I
    [J]. JOURNAL OF PSYCHOPHYSIOLOGY, 2004, 18 (01) : 46 - 46